The World Health Organization on Monday temporarily suspended its trial of hydroxycholoroquine, the drug backed by President Donald Trump to combat the deadly coronavirus, over safety concerns.
President Trump took it to social media on March 21 to express his thoughts saying, "HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game-changers in the history of medicine".
"The Department will be updating its advice that hydroxychloroquine use in treating COVID-19 is strongly discouraged including in hospitalised patients unless the patient is enrolled in a clinical trial, noting that now numbers hospitalised in Australia are very low, at this stage only 30, and there are fewer than 500 active cases across Australia", said a spokesperson from the TGA.
The decision to pause the trial was done out of an abundance of caution while safety data is reviewed. In April, the Food and Drug Administration warned against using the drug outside of hospitals and clinical trials over reports of "serious heart rhythm problems" linked to the drug's use.
Meanwhile the Australian COVID-SHIELD clinical trial on hydroxychloroquine treatment for the virus is reportedly still continuing.
The review panel will also check on seven other studies globally including the Recovery Trial in the United Kingdom that are using hydroxychloroquine for COVID-19 patients to see if they are seeing similar problems. She says the World Health Organization hasn't yet seen data that showed a problem with hydroxychloroquine in its own study but The Lancet article raised questions among numerous investigators involved in the WHO's trial.
"WHO will provide further updates as we know more". "Hopefully they will BOTH (H works better with A, International Journal of Antimicrobial Agents)".
'Finished, just finished, ' the commander-in-chief said.
Last week, Trump announced he was taking hydroxychloroquine although he has not tested positive for COVID-19. 'I figured maybe it's a good thing to take a program'.
The White House declined to comment.
Researchers found no benefit for coronavirus patients taking the drugs.
The authors suggested that hydroxychloroquine and chloroquine should not be used to treat COVID-19 outside of clinical trials until studies confirm their safety and efficacy in such patients.